Unknown

Dataset Information

0

Therapeutic Benefit of Top-Selling Oncology Drugs in Medicare.

ABSTRACT:

SUBMITTER: Wang S 

PROVIDER: S-EPMC11971663 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Therapeutic Benefit of Top-Selling Oncology Drugs in Medicare.

Wang Stephanie S   Egilman Alexander C AC   Hahn Georg G   Kesselheim Aaron S AS  

JAMA network open 20250401 4

Similar Datasets

Unknown Added Therapeutic Benefit of Top-Selling Brand-name Drugs in Medicare.
| S-EPMC10114018 | biostudies-literature
Unknown Revenue Differences Between Top-Selling Small-Molecule Drugs and Biologics in Medicare.
| S-EPMC12534848 | biostudies-literature
Unknown Added Therapeutic Benefits of Top-Selling Drugs in Japan: A Cross-Sectional Study Using Health Technology Assessment.
| S-EPMC12105913 | biostudies-literature
Unknown Therapeutic benefit of the most expensive drugs covered by Medicare and Medicaid.
| S-EPMC12490368 | biostudies-literature
Unknown Spending For Orphan Indications Among Top-Selling Orphan Drugs Approved To Treat Common Diseases.
| S-EPMC8011952 | biostudies-literature
Unknown Estimating Costs of Market Exclusivity Extensions For 4 Top-Selling Prescription Drugs in the US.
| S-EPMC12374220 | biostudies-literature
Unknown Incorporating Added Therapeutic Benefit and Domestic Reference Pricing Into Medicare Payment for Expensive Part B Drugs.
| S-EPMC11376011 | biostudies-literature
Unknown Utilization Management Trends in Medicare Part D Oncology Drugs, 2010-2020.
| S-EPMC10354675 | biostudies-literature
Unknown Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019.
| S-EPMC9857139 | biostudies-literature
Unknown Packaging Characteristics of Top-Selling Cigars in the United States, 2018.
| S-EPMC9575977 | biostudies-literature